Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreina Manfredi

Showing results (41-50 of 112) with videos related to

Pageof 12
Sort By:
Clinical and Experimental Rheumatology|August 6, 2015
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentanMarco Sebastiani, Andreina Manfredi, Valentina Cestelli, et al.
The Journal of Rheumatology|June 17, 2016
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific PatternAndreina Manfredi, Marco Sebastiani, Federica Campomori, et al.
Clinical and Experimental Rheumatology|March 26, 2024
Factors associated to long-term retention rate of Janus kinase inhibitors in a multi-failure rheumatoid arthritis populationMarco Sebastiani, Alen Zabotti, Bruno Biasi, et al.
Frontiers in Medicine|January 26, 2023
Radiomics to predict the mortality of patients with rheumatoid arthritis-associated interstitial lung disease: A proof-of-concept studyVincenzo Venerito, Andreina Manfredi, Giuseppe Lopalco, et al.
Drugs in Context|January 28, 2021
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applicationsGian Luca Erre, Marco Sebastiani, Andreina Manfredi, et al.
Clinical Rheumatology|March 22, 2017
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvementAndreina Manfredi, Marco Sebastiani, Stefania Cerri, et al.
Case Reports in Medicine|December 18, 2023
COVID-19, A New Possible Mimicker of Interstitial Lung Disease Related to Primary Sjögren's SyndromeAlessia Laneri, Stefania Cerri, Giovanni Della Casa, et al.
Clinical Rheumatology|April 27, 2017
Erratum to: Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvementAndreina Manfredi, Marco Sebastiani, Stefania Cerri, et al.
Case Reports in Medicine|May 12, 2021
Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid ArthritisCaterina Vacchi, Andreina Manfredi, Giulia Cassone, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|March 18, 2025
Efficacy and safety of mepolizumab in eosinophilic granulomatosis with polyangiitis: Insights from real-life cases and literature analysisGiulia Cassone, Marco Sebastiani, Pierluigi Cataleta, et al.
Pageof 12

Showing results (41-50 of 112) with videos related to

Sort By:
Pageof 12
Clinical and Experimental Rheumatology|August 6, 2015
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentanMarco Sebastiani, Andreina Manfredi, Valentina Cestelli, et al.
The Journal of Rheumatology|June 17, 2016
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific PatternAndreina Manfredi, Marco Sebastiani, Federica Campomori, et al.
Clinical and Experimental Rheumatology|March 26, 2024
Factors associated to long-term retention rate of Janus kinase inhibitors in a multi-failure rheumatoid arthritis populationMarco Sebastiani, Alen Zabotti, Bruno Biasi, et al.
Frontiers in Medicine|January 26, 2023
Radiomics to predict the mortality of patients with rheumatoid arthritis-associated interstitial lung disease: A proof-of-concept studyVincenzo Venerito, Andreina Manfredi, Giuseppe Lopalco, et al.
Drugs in Context|January 28, 2021
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applicationsGian Luca Erre, Marco Sebastiani, Andreina Manfredi, et al.
Clinical Rheumatology|March 22, 2017
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvementAndreina Manfredi, Marco Sebastiani, Stefania Cerri, et al.
Case Reports in Medicine|December 18, 2023
COVID-19, A New Possible Mimicker of Interstitial Lung Disease Related to Primary Sjögren's SyndromeAlessia Laneri, Stefania Cerri, Giovanni Della Casa, et al.
Clinical Rheumatology|April 27, 2017
Erratum to: Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvementAndreina Manfredi, Marco Sebastiani, Stefania Cerri, et al.
Case Reports in Medicine|May 12, 2021
Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid ArthritisCaterina Vacchi, Andreina Manfredi, Giulia Cassone, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|March 18, 2025
Efficacy and safety of mepolizumab in eosinophilic granulomatosis with polyangiitis: Insights from real-life cases and literature analysisGiulia Cassone, Marco Sebastiani, Pierluigi Cataleta, et al.
Pageof 12